OptiNose, Inc. - stock earnings
OPTN Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -10.0 million USD | 19.9 million USD |
2023Q3 | -9.3 million USD | 19.8 million USD |
2023Q2 | 2.6 million USD | 19.5 million USD |
2023Q1 | -18.7 million USD | 11.8 million USD |
2022Q4 | -17.3 million USD | 20.9 million USD |
2022Q3 | -14.9 million USD | 20.1 million USD |
2022Q2 | -19.4 million USD | 20.6 million USD |
2022Q1 | -25.3 million USD | 14.8 million USD |
2021Q4 | -15.6 million USD | 22.5 million USD |
2021Q3 | -17.1 million USD | 21.8 million USD |
2021Q2 | -23.5 million USD | 18.4 million USD |
2021Q1 | -26.1 million USD | 12.0 million USD |
2020Q4 | -23.9 million USD | 16.3 million USD |
2020Q3 | -21.2 million USD | 15.4 million USD |
2020Q2 | -25.9 million USD | 10.3 million USD |
2020Q1 | -28.9 million USD | 7.1 million USD |
2019Q4 | -25.0 million USD | 11.1 million USD |
2019Q3 | -28.8 million USD | 12.4 million USD |
2019Q2 | -27.4 million USD | 6.7 million USD |
2019Q1 | -28.9 million USD | 4.5 million USD |
2018Q4 | -26.4 million USD | 3.0 million USD |
2018Q3 | -25.1 million USD | 1.9 million USD |
2018Q2 | -24.6 million USD | 1.3 million USD |
2018Q1 | -30.6 million USD | 865000 USD |
2017Q4 | -19.6 million USD | ? USD |
2017Q3 | -13.1 million USD | 30000 USD |
2017Q2 | -8.2 million USD | ? USD |
2017Q1 | -8.1 million USD | ? USD |
2016Q4 | -5.6 million USD | 47.5 million USD |
2016Q3 | -6.1 million USD | 47.5 million USD |
2016Q2 | 34.3 million USD | 47.5 million USD |
2015Q4 | -28.3 million USD | 85000 USD |
OPTN Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -35.5 million USD | 71.0 million USD |
2022 | -76.4 million USD | 76.3 million USD |
2021 | -81.7 million USD | 74.7 million USD |
2020 | -98.3 million USD | 49.1 million USD |
2019 | -108.9 million USD | 34.6 million USD |
2018 | -106.7 million USD | 7.1 million USD |
2017 | -48.9 million USD | 162000 USD |
2016 | 22.6 million USD | 47.5 million USD |
2015 | -28.3 million USD | 85000 USD |
OPTN
Price: $0.88
52 week price:
Earnings Per Share: -0.32 USD
P/E Ratio: -3.21
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 133800
Ebitda: -13.0 millionMarket Capitalization: 139.7 million